The pathways study: A randomized trial of collaborative care in patients with diabetes and depression

Archives of General Psychiatry

Volumn 61, Issue 10, 2004, Pages 1042-1049

  Katon, Wayne J ^a,c   Von Korff, Michael ^b   Lin, Elizabeth H B ^b   Simon, Greg ^b   Ludman, Evette ^b   Russo, Joan ^a   Ciechanowski, Paul ^a   Walker, Edward ^a   Bush, Terry ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HEMOGLOBIN A; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DYSTHYMIA; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK; TIME; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CASE MANAGEMENT; COMORBIDITY; DELIVERY OF HEALTH CARE; DEPRESSIVE DISORDER; DIABETES MELLITUS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT SATISFACTION; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 5044229591     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.10.1042     Document Type: Article

References (45)

1. Anderson R, Freedland K, Clouse R, Lustman P. Prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069-1078.
2. Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27:914-920.
3. Eaton W, Armenian H, Gallo J, Pratt L, Ford D. Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care. 1996;19:1097-1102.
4. Carnethon M, Kinder L, Fair J, Stafford R, Fortmann S. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiology Follow-Up Study 1971-1992. Am J Epidemiol. 2003;158:416-423.
5. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25:246-252.
6. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278-3285.
7. Lustmart PJ, Anderson R, Freedland K, de Groof M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934-942.
8. de Groot M, Anderson R, Freedland K, Clouse RE, Lustman PJ. Association of depression and diabetes complications: meta-analysis. Psychosom Med. 2001;63:619-630.
9. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older persons with type 2 diabetes. Diabetes Care. 2003;26:1822-1828.
10. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes: results of 5-yr follow-up study. Diabetes Care. 1988;11:605-612.
11. Katon W, Russo J, Frank E, Barrett J, Williams JW Jr, Oxman T, Sullivan M, Cornell J. Predictors of nonresponse to treatment in primary care patients with dysthymia. Gen Hosp Psychiatry. 2002;24:20-27.
12. Cole M, Bellavance F, Marsour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry. 1999;156:1182-1189.
13. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59:241-250.
14. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:618-623.
15. Lijsiman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1998;129:613-621.
16. Williams J Jr, Katon W, Lin E, Nöel P, Worchel J, Cornell J, Harpole L, Fultz B, Hunkeler E, Mika V, Unützer J. Effectiveness of depression care management for older adults with coexisting depression and diabetes mellitus. Ann Intern Med. 2004;140:1015-1024.
17. Chin MH, Zhang JX, Merrell K. Specialty differences in the care of older patients with diabetes. Med Care. 2000;38:131-140.
18. Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized, controlled trial. Ann Intern Med. 1998;129:605-612.
19. Weinberger M, Kirkman MS, Samsa GP, Shortliffe EA, Landsman PB, Cowper PA, Simel DL, Feussner JR. A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med. 1995;10:59-66.
20. Katon W, Simon G, Russo J, Von Korff M, Lin EHB, Ludman E, Ciechanowski P, Bush T. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care. In press.
21. Grant RW, Hamrick HE, Sullivan CM, Dubey AK, Chueh HC, Cagliero E, Meigs JB. Impact of population management with direct physician feedback on care of patients with type 2 diabetes. Diabetes Care. 2003;26:2275-2280.
22. Derogatis L, Rickels K, Unlenhuth E, Coui C. The Hopkins Symptom Checklist: a measure of primary symptom dimensions. In: Pichot P, ed. Psychological Measurement in Psychopharmacology: Problems in Psychopharmacology. Basel, Switzerland; Kargerman; 1974:79-110.
23. McCulloch D, Price M, Hindmarsh M, Wagner E. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract. 1998;1:12-22.
24. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
25. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study: primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA. 1999;282:1737-1744.
26. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, Robinson P, Russo J. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.
27. Gwirtsman HE, Blehar MC, McCullough JP Jr, Kocsis JH, Prien RF. Standardized assessment of dysthymia: report of a National Institute of Mental Health conference. Psychopharmacol Bull. 1997;33:3-11.
28. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, Md: US Dept of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976:218-222. Revised DHEW publication WOADM 76-338.
29. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes Care. 1995;18:896-909.
30. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15:399-408.
31. Agency for Health Care Policy and Research. Depression in Primary Care: Treatment of Major Depression. Vol 2. Rockville, Md: US Dept of Health & Human Services, 1993. Publication AHCPR 93-0511.
32. Katzelnick DJ, Kobak KA, Jefferson JW, Greist JH, Henk HJ. Prescribing patterns of antidepressant medications for depression in an HMO. Formulary. 1996;31:374-388.
33. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman OJ, O'Keeffe Rosetti MC. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care. 2003;41:84-99.
34. Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26:53-74.
35. Rosenzweig JL, Weinger K, Poirier-Solomon L, Rushton M. Use of a disease seventy index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. Am J Manag Care. 2002;8:950-958.
36. Unützer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L, Hoffing M, Della Penna RD, Noel PH, Lin EH, Arean PA, Hegel MT, Tang L, Belin TR, Oishi S, Langston C; IMPACT Investigators. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-2845.
37. Mynors-Wallis L, Gath D, Lloyd-Thomas A, Tomlinson D. Randomized controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441-445.
38. Unützer J; IMPACT Investigators. IMPACT Intervention Manual. Los Angeles, Calif: Center for Health Services Research, UCLA Neuropsychiatric Institute; 1999.
39. Hegel MT, Barrett JE, Oxman TE. Training therapists in problem-solving treatment of depressive disorders in primary care (PST-PC): lessons learned from the Treatment Effectiveness Project. Fam Syst Health. 2000;18:423-435.
40. Hegel MT, Arean P. Problem-solving Treatment for Primary Care (PST-PC): A Treatment Manual for Depression. Hanover, NH: Dartmouth University Press; 2003.
41. Katon W, Von Korff M, Lin E, Simon G. Rethinking practitioner roles in chronic illness: the specialist, primary care physician, and the practice nurse. Gen Hosp Psychiatry. 2001;23:138-144.
42. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Database Syst Rev. 2000;4:CD001312.
43. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon G, Walker E. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932.
44. Keller MB, McCullough JP, Klein DW, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.
45. Kinder L, Kamarck T, Baum A, Orchard T. Depressive symptomatology and coronary heart disease in type 1 diabetes mellitus: a study of possible mechanisms. Health Psychol. 2002;21:542-552.